WHO WE ARE
Our mission is to develop genetic tests which become the model for comprehensive disease detection and informed treatment. Iverson Genetic Diagnostics is a biotech company focused on the next generation of healthcare. Our management team holds extensive experience managing privately funded research laboratories. We have demonstrated a successful history directing emerging growth companies and hold a comprehensive understanding small to mid-size business financing and securities compliance. Our advisory board lends a diverse wealth of knowledge to our efforts, representing a broad range of expertise in the medical and scientific community with a proven track record from leaders in the International business community. We have joined forces behind the revolutionary idea of predictive, preventive and affordable health care.
|
|
|
WHAT WE DO
Iverson Genetic Diagnostics, Inc. specializes in offering DNA/RNA or SNP analysis and late stage analysis tools for medical providers to assess health. We focus on disorders which are preventable or treatable. We offer a Clinical Laboratory Improvement Amendments (CLIA) certified laboratory, rapid turnaround time, detailed reports and superior customer service. Our company is also developing an exclusive genetic diagnostic testing method which allows for the detection and diagnosis of multiple genetic conditions, genetic and infectious diseases and neurotoxic genetic signatures. In addition, we offer lab services to the research community.
|
|
|
WHY IT MATTERS
Empowering People to Extend and Improve their Lives. The completion of the Human Genome Project, with its decoding of nearly 30,000 genes in the human body, opened up an entirely new spectrum of knowledge, one offering a tremendous potential for improving human health and well-being. Genetic diagnostic testing can benefit virtually every individual by giving them a comprehensive tool to assess their health. By understanding their predispositions to a broad spectrum of diseases, individuals are able to take preventative measures to mitigate their risk. Early detection is the key to success. It will provide physicians and their patients with profound insights into their lives and the interactive disease process. Physicians will be able to mitigate substantial health care costs and be able to intervene more quickly, confidently and effectively in the interest of promoting optimal health for their patients.
|
|
|
